Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 985 products on this category.

Product data	Purity	Price range	Estimated delivery
Carfilzomib REF: 4Z-C-121001CAS: 868540-17-4	- - -	To inquire	Mon 16 Dec 24
Goserelin EP Impurity D Ditrifluoroacetate REF: 4Z-PG-1511	- - -	To inquire	Mon 16 Dec 24
Goserelin Impurity 5 Ditrifluoroacetate (6-(des-tert-Butyl-D-Serine)-Goserelin Ditrifluoroacetate) REF: 4Z-PG-1520CAS: 65807-03-6	- - -	To inquire	Mon 16 Dec 24
Bestatin Impurity 5 REF: 4Z-B-119008CAS: 147169-48-0	- - -	To inquire	Mon 16 Dec 24
Fulvestrant (R enantiomer) REF: TM-T11334CAS: 1807900-80-6	98%	To inquire	Mon 16 Dec 24
Goserelin EP Impurity B Diacetate ((Ser(tBu)6)-Goserelin Diacetate) REF: 4Z-PG-154CAS: 184686-52-0	- - -	To inquire	Mon 16 Dec 24
Olaparib Impurity 5 (2-Bromopropane) REF: 4Z-O-032007CAS: 75-26-3	- - -	To inquire	Mon 16 Dec 24
Enzalutamide Impurity 12 REF: 4Z-E-068025CAS: 1802242-43-8	- - -	To inquire	Mon 16 Dec 24
Carfilzomib Impurity 18 REF: 4Z-C-121021	- - -	To inquire	Mon 16 Dec 24
Olaparib Impurity 17 REF: 4Z-O-032019CAS: 632-22-4	- - -	To inquire	Mon 16 Dec 24
Abiraterone N-Oxide REF: 4Z-A-8216CAS: 2378463-76-2	- - -	To inquire	Mon 16 Dec 24
Palbociclib Impurity 8 REF: 4Z-P-196012CAS: 827022-31-1	- - -	To inquire	Mon 16 Dec 24
Palbociclib N-Glucuronide REF: 4Z-P-196006	- - -	To inquire	Mon 16 Dec 24
Enzalutamide Impurity 2 REF: 4Z-E-068010CAS: 143782-23-4	- - -	To inquire	Mon 16 Dec 24
Nintedanib Impurity 42 REF: 4Z-N-066060CAS: 676326-36-6	- - -	To inquire	Mon 16 Dec 24
Palbociclib Impurity 81 REF: 4Z-P-196091CAS: 1082876-26-3	- - -	To inquire	Mon 16 Dec 24
Palbociclib Impurity 26 REF: 4Z-P-196030CAS: 2458234-37-0	- - -	To inquire	Mon 16 Dec 24
Carfilzomib Impurity 79 REF: 4Z-C-121082	- - -	To inquire	Mon 16 Dec 24
Folinic Acid EP Impurity B (Mixture of Diastereomers) REF: 4Z-F-068003CAS: 98814-60-9	- - -	To inquire	Mon 16 Dec 24
17-Keto Fulvestrant REF: 4Z-F-317CAS: 403656-89-3	- - -	To inquire	Mon 16 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Carfilzomib

Ref: 4Z-C-121001

Goserelin EP Impurity D Ditrifluoroacetate

Ref: 4Z-PG-1511

Goserelin Impurity 5 Ditrifluoroacetate (6-(des-tert-Butyl-D-Serine)-Goserelin Ditrifluoroacetate)

Ref: 4Z-PG-1520

Bestatin Impurity 5

Ref: 4Z-B-119008

Fulvestrant (R enantiomer)

Ref: TM-T11334

Goserelin EP Impurity B Diacetate ((Ser(tBu)6)-Goserelin Diacetate)

Ref: 4Z-PG-154

Olaparib Impurity 5 (2-Bromopropane)

Ref: 4Z-O-032007

Enzalutamide Impurity 12

Ref: 4Z-E-068025

Carfilzomib Impurity 18

Ref: 4Z-C-121021

Olaparib Impurity 17

Ref: 4Z-O-032019

Abiraterone N-Oxide

Ref: 4Z-A-8216

Palbociclib Impurity 8

Ref: 4Z-P-196012

Palbociclib N-Glucuronide

Ref: 4Z-P-196006

Enzalutamide Impurity 2

Ref: 4Z-E-068010

Nintedanib Impurity 42

Ref: 4Z-N-066060

Palbociclib Impurity 81

Ref: 4Z-P-196091

Palbociclib Impurity 26

Ref: 4Z-P-196030

Carfilzomib Impurity 79

Ref: 4Z-C-121082

Folinic Acid EP Impurity B (Mixture of Diastereomers)

Ref: 4Z-F-068003

17-Keto Fulvestrant

Ref: 4Z-F-317